Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Oral Oncol. 2019 Jun 4;95:11–15. doi: 10.1016/j.oraloncology.2019.05.016

Figure 2.

Figure 2.

Prevalence of high concern (on a three point scale) among patients with human papillomavirus-associated oropharyngeal cancer regarding treatment-related issues at diagnosis and after treatment. *p=0.0008-0.04